A new study has demonstrated a way to reduce vitamin D receptor activity selectively in bone or muscle in living mice, using engineered adeno-associated viral vectors. The work, reported by O’Donohue, Chu, Norris and colleagues in Gene Therapy, provides a molecular toolkit for studying how vitamin D signaling operates in